Literature DB >> 11407710

Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?

M M Ward1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11407710     DOI： 10.1002/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

1.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

2.  Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.

Authors:  Ted R Mikuls; Brian T Fay; Kaleb Michaud; Harlan Sayles; Geoffrey M Thiele; Liron Caplan; Dannette Johnson; John S Richards; Gail S Kerr; Grant W Cannon; Andreas Reimold
Journal:  Rheumatology (Oxford)       Date:  2010-07-21       Impact factor: 7.580

3.  Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.

Authors:  T R Mikuls; K G Saag; L A Criswell; L A Merlino; R A Kaslow; B J Shelton; J R Cerhan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

4.  The risk of comorbidity.

Authors:  J C Peterson; S A Paget; M S Lachs; M C Reid; M E Charlson
Journal:  Ann Rheum Dis       Date:  2012-01-18       Impact factor: 19.103

Review 5.  Co-morbidity index in rheumatoid arthritis: time to think.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2015-10-26       Impact factor: 2.980

6.  Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.

Authors:  Mary Chester M Wasko; Abhijit Dasgupta; Helen Hubert; James F Fries; Michael M Ward
Journal:  Arthritis Rheum       Date:  2013-02

7.  Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study.

Authors:  C Turesson; A Jarenros; L Jacobsson
Journal:  Ann Rheum Dis       Date:  2004-03-29       Impact factor: 19.103

8.  Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.

Authors:  Hyung Ran Yun; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

9.  Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.

Authors:  Dimitrios A Pappas; Fredrik Nyberg; Joel M Kremer; Kathy Lampl; George W Reed; Laura Horne; Meilien Ho; Alina Onofrei; Anand N Malaviya; Oscar L Rillo; Sebastiao C Radominski; Janos Gal; Allan Gibofsky; Tatiana V Popkova; Leda Laurindo; Eduardo M Kerzberg; Roman Zahora; Bernado A Pons-Estel; Jeffrey R Curtis; Daniel E Furst; Jeffrey D Greenberg
Journal:  Clin Rheumatol       Date:  2018-04-25       Impact factor: 2.980

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.